Alan L. Fuchsberg
Direttore/Membro del Consiglio presso ARMGO Pharma, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Eugene Marcantonio | M | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 7 anni |
Andrew R. Marks | M | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 20 anni |
Anthony Welters | M | 69 |
New York University School of Law
| - |
Karen L. Katen | F | 75 |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | - |
Gerald Rosenfeld | M | 77 |
New York University School of Law
| - |
David Tanner | M | 65 |
New York University School of Law
| - |
Yael Webb | M | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | - |
Vincent Tese | M | 81 |
New York University School of Law
| 34 anni |
Paul Gideon van Zyl | M | 55 |
New York University School of Law
| - |
Kathryn Sudol | F | 49 |
New York University School of Law
| - |
Benedict Kingsbury | M | - |
New York University School of Law
| - |
Mitra O'Neill | F | 55 |
New York University School of Law
| - |
Stewart Pollock | M | - |
New York University School of Law
| - |
Peter Sudler | M | - |
New York University School of Law
| - |
Mimi Marziani | F | - |
New York University School of Law
| - |
Jennifer Arlen | F | - |
New York University School of Law
| - |
Murray Bring | M | - |
New York University School of Law
| - |
Sandro Belvedere | M | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 18 anni |
Steven Tuttleman | M | - |
New York University School of Law
| 4 anni |
Kathi Larson | F | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 18 anni |
Scott Hoffman | M | 61 |
New York University School of Law
| - |
Rachel Robbins | F | 73 |
New York University School of Law
| - |
Tom Shropshire | M | - |
New York University School of Law
| - |
John Suydam | M | 64 |
New York University School of Law
| - |
Vijaya Gadde | F | 49 |
New York University School of Law
| - |
Jeff Aronson | M | 66 |
New York University School of Law
| - |
Roger Meltzer | M | 73 |
New York University School of Law
| 13 anni |
Richard Reiss | M | 80 |
New York University School of Law
| - |
Mitchell Jacobson | M | 73 |
New York University School of Law
| - |
Trevor Morrison | M | 53 |
New York University School of Law
| 11 anni |
Dean Garfield | M | 56 |
New York University School of Law
| 3 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 31 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Alan L. Fuchsberg
- Contatti personali